Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evofosfamide and doxorubicin in advanced soft tissue sarcoma
NCT00742963Phase 2Completed
- Sponsor
- ImmunoGenesis
- Start
- Aug 2008
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of evofosfamide in soft tissue sarcoma (STS), sponsored by ImmunoGenesis. Started Aug 2008; status: completed.
02
Drugs
evofosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00742963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742963.